Immunomedics, Inc., (Nasdaq: IMMU) announced the issuance of U.S. Patent 9,375,489, entitled “Antibody-SN-38 Immunoconjugates with a CL2A Linker.” This is ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE